Background illustration for clinical trials search

Paid Clinical Trials Annapolis

Discover 2,396 paid clinical trials in Annapolis, Maryland. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter

Filter results

Results: 2,396

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

for

Polycythemia Vera

Location: Bethesda MD, The Bronx NY, Canton OH, Grand Rapids MI,

Sponsor: Ono Pharmaceutical Co., Ltd.

Sex: All

Age: 18+

Code: NCT07429266

Phase3, Recruiting

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

for

Chronic Lymphocytic Leukemia

Location: Bethesda MD

Sponsor: National Heart, Lung, and Blood Institute (NHLBI)

Sex: All

Age: 18 - 70+

Code: NCT03986034

Phase2, Recruiting

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

for

Familial Cancer, BRCA1-Associated Protein-1 (BAP1) Mutations,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 30 - 70+

Code: NCT04431024

Recruiting

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

for

Alpha and Beta Thalassemia, Sickle Cell Disease, Malaria,

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70

Code: NCT03937817

Recruiting

Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects

for

Normal Physiology

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 18 - 70+

Code: NCT05604534

Recruiting

Natural History of Inflammatory Muscle Diseases

for

Inflammation In Skeletal Muscle

Location: Bethesda MD

Sponsor: National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

Sex: All

Age: 2 - 70+

Code: NCT05738824

Recruiting

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

for

Idiopathic CD4-Positive, T-Lymphocytopenia

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 65

Code: NCT02015013

Phase2, Recruiting

Genetic Studies of Chronic Active Epstein-Barr Disease

for

Chronic Active Epstein-Barr Virus

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 1 - 70+

Code: NCT00032513

Recruiting

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

for

Brain Tumor, Cancer

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 15+

Code: NCT05588141

Phase1, Phase2, Recruiting

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

for

Schizophrenia

Location: Gaithersburg MD, Marlton NJ, Philadelphia PA,

Sponsor: MapLight Therapeutics

Sex: All

Age: 18 - 65

Code: NCT07459647

Phase2, Recruiting

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

for

X-linked Severe Combined Immunodeficiency (XSCID)

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: Male

Age: 2 - 50

Code: NCT01306019

Phase1, Phase2, Recruiting

Evaluation and Treatment of Neurosurgical Disorders

for

Neurologic Disorders

Location: Bethesda MD

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS)

Sex: All

Age: 4 - 70+

Code: NCT00060541

Recruiting

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

for

Kaposi Sarcoma

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT04303117

Phase1, Phase2, Recruiting

Studies of Disorders With Increased Susceptibility to Fungal Infections

for

Fungal Infections, Primary Immune Deficiencies

Location: Bethesda MD

Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)

Sex: All

Age: 18 - 70+

Code: NCT01222741

Recruiting

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

for

Metastatic Castration-resistant Prostate Cancer

Location: Rockville MD, Fairfax VA, Norfolk VA, White Plains NY,

Sponsor: BioNTech SE

Sex: Male

Age: 18+

Code: NCT07365995

Phase3, Recruiting

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

for

Neuroendocrine Tumors, Carcinoma, Neuroendocrine

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT05237934

Recruiting

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

for

HIV, Kaposi's Sarcoma, Lymphomas,

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT00006518

Recruiting

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

for

GATA2, Immunodeficiency, MDS

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 6 - 70

Code: NCT01861106

Phase2, Recruiting

Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

for

Healthy Volunteer

Location: Bethesda MD

Sponsor: National Cancer Institute (NCI)

Sex: All

Age: 18 - 70+

Code: NCT02821806

Recruiting

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL

for

CLL / SLL, CLL (Chronic Lymphocytic Leukemia), CLL, Refractory,

Location: Bethesda MD, Skokie IL, Las Vegas NV, Spokane WA

Sponsor: Newave Pharmaceutical Inc

Sex: All

Age: 18+

Code: NCT07342478

Phase3, Recruiting

Paid Clinical Trials Annapolis

Filter results

INTREPID: A Study of Sapablursen Evaluating the Safety and Efficacy in Participants With Polycythemia Vera (PV)

Early Clonal Dynamics During Venetoclax Treatment for Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL)

Prospective Evaluation of High Resolution Dual Energy Computed Tomographic Imaging, Noninvasive (Liquid) Biopsies, and Minimally Invasive Surgical Surveillance for Early Detection of Mesotheliomas in Patients With BAP1 Tumor Predisposition Syndrome

Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants

Assessing and Improving Quantitative Magnetic Resonance Imaging Metrics in Human Subjects

Interested in new trials?

Natural History of Inflammatory Muscle Diseases

Hematopoietic Stem Cell Mobilization in Idiopathic CD4 Lymphocytopenia Patients and Healthy Controls for the Study of T Cell Maturation and Trafficking in Murine Models

Genetic Studies of Chronic Active Epstein-Barr Disease

A Phase I/II Study of Zotiraciclib for Recurrent Malignant Gliomas With Isocitrate Dehydrogenase 1 or 2 (IDH1 or IDH2) Mutations

A Long-Term Open-Label Study of ML-007C-MA in Adults With Schizophrenia

Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)

Evaluation and Treatment of Neurosurgical Disorders

PDS01ADC Monotherapy and in Combination With M7824 in Advanced Kaposi Sarcoma

Studies of Disorders With Increased Susceptibility to Fungal Infections

A Phase III Trial of BNT324 Versus Docetaxel in Metastatic Castration-resistant Prostate Cancer

Tissue Procurement and Natural History Study of Neuroendocrine Neoplasms (NENs) Including Adrenocortical Carcinoma (ACC)

Specimen Collections From Participants With HIV Infection, KSHV Infection, Viral-Related Pre-malignant Lesions and Cancer

Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations

Collection of Peripheral Blood Mononuclear Cells (PBMCs) From Healthy People for the Expansion of T Cells for Adoptive Cell Therapy

ROCKET-CLL Global Phase 3 Study: Rocbrutinib vs Pirtobrutinib in cBTKi-Pretreated R/R CLL/SLL